Cancers, Vol. 16, Pages 1510: Synergistic Activity of DNA Damage Response Inhibitors in Combination with Radium-223 in Prostate Cancer

This study identified the ATR inhibitor as the most synergistic inhibitor for both radiation qualities, supporting further pre-clinical evaluation of DDR inhibitors in combination with 223Ra for the treatment of prostate cancer.

Source: Cancers - April 15, 2024 Category: Cancer & Oncology Authors: Victoria L. Dunne Timothy C. Wright Francisco D. C. Guerra Liberal Joe M. O ’Sullivan Kevin M. Prise Tags: Article Source Type: research